Inventor

CHARVET RICHARD

FR20 patents

⚠️ This page may combine multiple inventors who share the name “CHARVET RICHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHARVET RICHARD

ADOCIA

Rapid-acting insulin formulation comprising a substituted anionic compound

Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound

Rapid-acting insulin formulation comprising a substituted anionic compound

Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid

Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid

Rapid-acting insulin composition comprising a substituted citrate

Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

Injectable solution at pH 7 comprising at least one basal insulin for which the pI is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid

Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid

Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid

Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid

Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer

CHARVET RICHARD

Anionic polysaccharides functionalized by a hydrophobic acid derivative

Functionalized oligosaccharides

Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer

SOULA REMI

Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative